Treatment of uterine fibroid with triptorelin before hysterectomy.
OBJECTIVE
To study the effects of pretreatment with triptorelin on uterine fibroid before abdominal hysterectomy.


METHODS
Fifteen premenopausal Chinese women with symptomatic uterine fibroids requiring hysterectomy were recruited in the study. All patients received monthly intramuscular injections of 3.75 mg triptorelin for three months prior to abdominal hysterectomy.


RESULTS
There was significant reduction in the serum levels of oestradiol (68.6%), progesterone (95.6%) and luteinizing hormone (73.9%) and in uterine (45.0%) and fibroid (68.0%) volumes. The serum level of follicle-stimulating hormone and haemoglobin concentration were not significantly different.


CONCLUSIONS
Shrinkage of uterine fibroids can be achieved in women who are rendered hypoestrogenic with monthly injections of triptorelin for three months. This treatment modality may be of value prior to hysterectomy or myomectomy especially when the fibroid is large.
D000328:Adult; D017024:Chemotherapy, Adjuvant; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007273:Injections, Intramuscular; D007889:Leiomyoma / Q000188:drug therapy* / Q000601:surgery; D008186:Luteolytic Agents / Q000627:therapeutic use*; D008875:Middle Aged; D011300:Preoperative Care; D017329:Triptorelin Pamoate / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy* / Q000601:surgery